Dynex Capital, Inc., a mortgage real estate investment trust, invests in mortgage-backed securities (MBS) in the United States. It invests in agency MBS consisting of residential MBS and commercial MBS (CMBS); and agency and non-agency CMBS interest-only securities. Agency MBS have a guaranty of principal payment by an agency of the U.S. government or a U.S. government-sponsored entity, such as Fannie Mae and Freddie Mac. Non-Agency MBS do not have a guaranty of principal or interest payments. The company has qualified as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal income taxes if it distributes at least 90% of its taxable income to its shareholders. Dynex Capital, Inc. was incorporated in 1987 and is headquartered in Glen Allen, Virginia.

Dynex Capital, Inc.

U.S. stocks finished a strong week with another rally on Friday after a surprisingly weak jobs report pushed investors to rethink the path for inte...

The Week That Was, The Week Ahead: Macro and Markets, August 9

Paradox Interactive (($SE:PDX)) has held its Q2 earnings call. Read on for the main highlights of the call. Paradox Interactive’s latest earnings c...

Paradox Interactive boosts profits and cash flow

General Dynamics ( ($GD) ) just unveiled an update. On August 5, 2026, General Dynamics’ board of directors elected company president Danny Deep, 5...

General Dynamics Elects President Danny Deep to Board

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Zoetis (ZTS) and Celldex (CLDX). Zoetis (ZTS) In a report release...

Analysts Offer Insights on Healthcare Companies: Zoetis (ZTS) and Celldex (CLDX)

In a report released today, Richard Law CFA from Goldman Sachs maintained a Hold rating on Celldex, with a price target of $38.00. According to Tip...

Goldman Sachs Reaffirms Their Hold Rating on Celldex (CLDX)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Korro Bio (KRRO), Ardelyx (ARDX) and Kymera Therapeutics (KYMR). ...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Korro Bio (KRRO), Ardelyx (ARDX) and Kymera Therapeutics (KYMR)

Lumos Diagnostics Holdings Ltd. ( ($AU:LDX) ) has issued an update. Lumos Diagnostics Holdings Ltd, a leader in rapid point-of-care diagnostic tech...

Lumos Diagnostics to Showcase Infection-Focused POC Tech at Bioshares Summit

An announcement from Ardelyx ( ($ARDX) ) is now available. Ardelyx reported that in the second quarter ended June 30, 2026, total product revenue r...

Ardelyx Updates Outlook Amid Q2 Growth and Recalibration

The Dixie Group ( ($DXYN) ) has provided an announcement. In August 2026, The Dixie Group released updated investor presentation materials outlinin...

The Dixie Group Updates Investor Presentation Amid Market Downturn

Paradox Interactive AB ( ($SE:PDX) ) just unveiled an announcement. Paradox Interactive delivered solid growth in the second quarter of 2026, with ...

Paradox Interactive lifts Q2 profit on strong franchises and moves to Nasdaq main market

Dimerix Limited ( ($AU:DXB) ) has provided an announcement. Dimerix Limited, a clinical-stage biopharmaceutical group, is building a specialised po...

Dimerix highlights kidney disease pipeline and diversification strategy at Bioshares Summit

Destination XL ( ($DXLG) ) has shared an update. On February 4, 2026, Destination XL Group received notice from Nasdaq that its shares had failed t...

Destination XL Transfers Listing to Nasdaq Capital Market

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Neuren Pharmaceuticals Limited (NURPF), Mettler-To...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Neuren Pharmaceuticals Limited (OtherNURPF), Mettler-Toledo (MTD) and Dexcom (DXCM)

Michael Burry, the investor best known for The Big Short, is sticking with his bearish outlook even as the stock market continues to climb. In a ne...

NVDA, MU, PLTR, TSLA: Michael Burry Keeps Betting Against AI Stocks, Warns of a ‘1987-Type Fall’

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on TG Therapeutics (TGTX), Syndax Pharmaceuticals (SN...

Analysts Offer Insights on Healthcare Companies: TG Therapeutics (TGTX), Syndax Pharmaceuticals (SNDX) and DaVita (DVA)

Citi analyst Daniel Grosslight maintained a Hold rating on Idexx Laboratories today and set a price target of $670.00. According to TipRanks, Gross...

Citi Keeps Their Hold Rating on Idexx Laboratories (IDXX)

General Dynamics ( ($GD) ) has issued an update. On August 4, 2026, General Dynamics filed a prospectus supplement with the SEC under its automatic...

General Dynamics Files Prospectus for Share Rescission Offer

Gold is often discussed as a retirement asset because it has a long history as a store of value, a hedge against inflation, and a diversifier durin...

Is Gold Good for Retirement Planning?

UBS analyst Sebastian Vogel maintained a Buy rating on Kardex AG today and set a price target of CHF346.00. According to TipRanks, Vogel is a 3-sta...

UBS Sticks to Their Buy Rating for Kardex AG (KARN)

In a report released today, Joseph House from Bell Potter maintained a Buy rating on Imdex Ltd, with a price target of A$4.60. According to TipRank...

Bell Potter Sticks to Their Buy Rating for Imdex Ltd (IMDXF)

Decent Holding Inc. ( ($DXST) ) has issued an announcement. Decent Holding Inc., incorporated in the Cayman Islands and listed on Nasdaq as DXST, o...

Decent Holding Files Interim Results and Accelerates Senior Care Expansion After Capital Restructuring

An announcement from Amundi SA ( ($FR:AMUN) ) is now available. Amundi has reported the latest activity under its 2026 share buyback programme, dis...

Amundi repurchases 200,000 shares under 2026 buyback programme

ADX Energy ( ($AU:ADX) ) has provided an update. ADX Energy Ltd has reported a change in the equity interests of director Paul Fink following the e...

ADX Energy Director Boosts Shareholding Through Option Exercise

Jefferies analyst Sheila Kahyaoglu maintained a Buy rating on General Dynamics today and set a price target of $460.00. According to TipRanks, Kahy...

General Dynamics (GD) Receives a Buy from Jefferies

MiMedx Group Inc. (($MDXG)) has held its Q2 earnings call. Read on for the main highlights of the call. MiMedx’s latest earnings call painted a pic...

MiMedx Earnings Call: Surgical Strength, Wound Strain

Analysts are intrested in these 5 stocks: ( ($INTU) ), ( ($GOOGL) ), ( ($HON) ), ( ($BDX) ) and ( ($SYK) ). Here is a breakdown of their recent


Intuit, Alphabet, Honeywell, BDX, Stryker Trending With Analysts

J.P. Morgan analyst Tien Tsin Huang maintained a Sell rating on DXC Technology today and set a price target of $12.00. According to TipRanks, Tsin ...

J.P. Morgan Reaffirms Their Sell Rating on DXC Technology (DXC)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on AptarGroup (ATR), Mettler-Toledo (MTD) and Dexcom (D...

Analysts Offer Insights on Healthcare Companies: AptarGroup (ATR), Mettler-Toledo (MTD) and Dexcom (DXCM)

In a report released today, from Susquehanna maintained a Hold rating on DXC Technology, with a price target of $10.00. In a report released today,...

DXC Technology (DXC) Receives a Hold from Susquehanna

In a report released yesterday, David Paige from RBC Capital maintained a Hold rating on DXC Technology, with a price target of $14.00. The company...

DXC Technology (DXC) Receives a Hold from RBC Capital

In a report released today, Keith Bachman from BMO Capital maintained a Hold rating on DXC Technology, with a price target of $11.00. According to ...

BMO Capital Sticks to Its Hold Rating for DXC Technology (DXC)

BTIG analyst Andre Madrid reiterated a Hold rating on General Dynamics yesterday. The company’s shares closed yesterday at $382.20. Madrid covers t...

General Dynamics (GD) Receives a Hold from BTIG

TD Cowen analyst Lance Vitanza maintained a Buy rating on JCDecaux SA today and set a price target of €28.00. According to TipRanks, Vitanza is a 5...

TD Cowen Remains a Buy on JCDecaux SA (0MGO)

Goldman Sachs analyst maintained a Buy rating on Amundi SA yesterday and set a price target of €97.00. The company’s shares closed yesterday at €94...

Amundi SA (0RDX) Receives a Buy from Goldman Sachs

An update from ADX Energy ( ($AU:ADX) ) is now available. ADX Energy Ltd has issued 2,959,011 ordinary fully paid shares without a disclosure docum...

ADX Energy Issues Shares Under Corporations Act Exemption

The latest update is out from ADX Energy ( ($AU:ADX) ). ADX Energy has applied for the quotation of 2,959,011 new ordinary fully paid shares on the...

ADX Energy Seeks ASX Quotation for New Share Issue

ADX Energy ( ($AU:ADX) ) just unveiled an update. ADX Energy reported a net cash outflow from operating activities of A$1.23 million in the June 20...

ADX Energy Posts Negative Cash Flow Amid Continued Investment in Production Assets

ADX Energy ( ($AU:ADX) ) has provided an announcement. ADX Energy reported average net production of 197 BOEPD for the June quarter, slightly down ...

ADX Energy boosts revenue on higher prices and advances Austrian gas and Sicily Channel prospects

4DMedical Ltd ( ($AU:4DX) ) has shared an update. 4DMedical reported a solid quarter with FY26 operating revenue rising 23% to $7.2 million, suppor...

4DMedical accelerates global rollout of CT:VQ™ as revenue and scan volumes surge

Aldeyra Therapeutics ( ($ALDX) ) just unveiled an update. On July 28, 2026, Aldeyra Therapeutics executed a lease agreement with Bradford Street, L...

Aldeyra Therapeutics Leases New Concord Headquarters Space

Jefferies analyst Sheila Kahyaoglu maintained a Buy rating on General Dynamics today and set a price target of $440.00. According to TipRanks, Kahy...

Amundi SA ( ($FR:AMUN) ) has shared an announcement. Amundi reported record first-half and second-quarter 2026 results, with adjusted net income up...

Amundi Posts Record First-Half Earnings as Assets and Inflows Hit New Highs

JCDecaux SA ( ($FR:DEC) ) has provided an update. JCDecaux reported first‑half 2026 revenue of €1.95 billion, up 5.7% organically, driven by strong...

JCDecaux Half‑Year 2026 Results Highlight Digital‑Led Growth and Margin Strength

ADX Energy ( ($AU:ADX) ) has shared an update. ADX Energy has issued 171,975,000 ordinary fully paid shares without a disclosure document, relying ...

ADX Energy Issues 171.9 Million Shares Under Disclosure Exemption

ADX Energy ( ($AU:ADX) ) has provided an announcement. ADX Energy Ltd has applied for the quotation of 171,975,000 new ordinary fully paid shares o...

ADX Energy Seeks ASX Quotation for 171.9 Million New Shares

Dexus ( ($AU:DXS) ) has provided an update. Dexus has agreed to sell its 50% stake in the Premium-grade 480 Queen Street office tower in Brisbane’s...

Dexus Sells Brisbane CBD Tower to Free Capital and Tighten Gearing

DXN Ltd. ( ($AU:DXN) ) has issued an announcement. DXN Limited has issued a correction to its Q4 FY26 investor presentation, clarifying that its ex...

DXN Corrects AI Module Timeline Description Without Changing Project Schedule

The latest announcement is out from MiMedx Group ( ($MDXG) ). On July 29, 2026, MiMedx agreed to acquire Sanara MedTech in a cash-and-stock merger ...

MiMedx Group to Acquire Sanara MedTech in Merger

A federal judge in Massachusetts has allowed part of a securities lawsuit against TransMedics Group (TMDX) to proceed, while dismissing several oth...

TransMedics Group Lawsuit Ruling: Court Allows Key Investor Claims Over Alleged Forced Bundling to Move Forward 

Canaccord Genuity analyst reiterated a Buy rating on Diaceutics today and set a price target of p215.00. Currently, the analyst consensus on Diaceu...

Diaceutics (DIUXF) Receives a Buy from Canaccord Genuity

In a report released today, Ivar Billfalk-Kelly from UBS maintained a Hold rating on Sodexo SA, with a price target of €57.50. According to TipRank...

UBS Remains a Hold on Sodexo SA (0J3F)

Redox Limited ( ($AU:RDX) ) just unveiled an update. Redox Limited, a major distributor of chemicals, ingredients and raw materials, plans to relea...

Redox Sets Date for FY26 Results and Investor Briefing

Mindax Limited ( ($AU:MDX) ) has issued an update. Mindax Limited’s June 2026 quarter was marked by steady advancement of its Mid-West Shared Infra...

Mindax advances Mid-West iron hub strategy and gold exploration in June quarter

DXN Ltd. ( ($AU:DXN) ) just unveiled an announcement. DXN Ltd., an ASX-listed provider of prefabricated modular data centre solutions, operates a v...

DXN Leans on Modular Data Centres as Core FY26 Revenue Driver

An update from Radiopharm Theranostics Limited Sponsored ADR ( ($RADX) ) is now available. On July 28, 2026, Radiopharm Theranostics closed a regis...

Radiopharm Theranostics Secures Multimillion-Dollar Financings to Advance Oncology Radiopharmaceutical Pipeline

The latest update is out from Dynex Capital ( ($DX) ). On July 28, 2026, Dynex Capital, Inc. amended its existing at-the-market equity distribution...

Dynex Capital Expands At-The-Market Equity Program

Lumos Diagnostics Holdings Ltd. ( ($AU:LDX) ) has issued an update. Lumos Diagnostics Holdings Ltd has disclosed a change in the shareholdings of d...

Lumos Diagnostics Updates Market on Director Doug Ward’s Increased Shareholding

Co-Diagnostics ( ($CODX) ) just unveiled an announcement. On July 27, 2026, Co-Diagnostics amended its October 20, 2025 equity distribution agreeme...

Co-Diagnostics Amends Equity Distribution, Extends Issuance Limits

There’s a lot to be optimistic about in the Energy sector as 2 analysts just weighed in on COSCO SHIPPING Energy Transportation Co (CSDXF) and Bake...

Analysts Are Bullish on These Energy Stocks: COSCO SHIPPING Energy Transportation Co (CSDXF), Baker Hughes Company (BKR)

Codexis ( ($CDXS) ) has shared an announcement. On July 23, 2026, Codexis, Inc. entered into an underwriting agreement with Piper Sandler & Co. and...

Codexis completes public equity offering to bolster liquidity

Amundi SA ( ($FR:AMUN) ) has shared an announcement. Amundi SA has continued to execute its 2026 share buyback program, reporting transactions on i...

Amundi Details July Transactions Under 2026 Share Buyback Program

Redox Limited ( ($AU:RDX) ) has issued an update. Redox Limited has scheduled its 2026 Annual General Meeting to be held as a hybrid event at Swiss...

Redox Sets Dates for 2026 AGM and Director Nomination Cut-Off

Lumos Diagnostics Holdings Ltd. ( ($AU:LDX) ) just unveiled an announcement. Lumos Diagnostics has released an investor presentation ahead of a roa...

Lumos Diagnostics Launches Investor Roadshow and Quarterly Results Webinar

Opthea ( ($AU:CYV) ) has shared an announcement. Ceryvyn Therapeutics reported quarterly progress marked by the reinstatement of its securities to ...

Ceryvyn Therapeutics Advances LAM Program After ASX Trading Reinstatement

Lumos Diagnostics Holdings Ltd. ( ($AU:LDX) ) just unveiled an update. Lumos Diagnostics reported a solid full-year performance for FY26, driven by...

Lumos Diagnostics FY26 Revenue Rises on FebriDx Surge Despite Services Slowdown

Key large-cap stock indexes closed down for the second consecutive week, as a combination of AI capex jitters and continued warfare in Iran weighed...

The AI Capex Reckoning: Markets Wobble as Google Spending Swells

Stocks ended the week mixed as strength in blue-chip shares offset losses in technology and semiconductor stocks. The Dow Jones Industrial Average ...

The Week That Was, The Week Ahead: Macro and Markets, July 26

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alkermes (ALKS) and Celldex (CLDX) with bullish sent...

Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS) and Celldex (CLDX)

MDxHealth ( ($MDXH) ) has provided an announcement. On July 20, 2026, MDxHealth received an additional notice from Nasdaq after its market value of...

MDxHealth Faces New Nasdaq Warning Over Market Value Shortfall

The latest announcement is out from FedEx ( ($FDX) ). On July 20, 2026, FedEx’s board approved a new Executive Severance Plan governing all future ...

FedEx Adopts New Executive Severance and Consulting Plan

Analysts have been eager to weigh in on the Industrial Goods sector with new ratings on Graco (GGG), Union Pacific (UNP) and FedEx (FDX). Graco (GG...

Analysts Offer Insights on Industrial Goods Companies: Graco (GGG), Union Pacific (UNP) and FedEx (FDX)

Codexis ( ($CDXS) ) has shared an update. Codexis disclosed a brief regulatory update indicating that the information previously reported under Ite...

Codexis Issues Brief Regulatory Filing Update Notice

The latest update is out from GridAI Technologies ( ($GRDX) ). On July 17, 2026, GridAI Technologies Corp. extended a $2 million secured convertibl...

GridAI Technologies Extends Secured Convertible Loan to Pronghorn

Integral Diagnostics Ltd. ( ($AU:IDX) ) has issued an update. Integral Diagnostics has re‑issued its notice to investors after a corrupted link in ...

Integral Diagnostics Resets FY26 Results Call After Link Issue

In a report released yesterday, from Berenberg Bank maintained a Hold rating on Sodexo SA, with a price target of €50.00. The company’s shares clos...

Berenberg Bank Remains a Hold on Sodexo SA (0J3F)

medmix AG ( ($CH:MEDX) ) just unveiled an update. medmix AG reported a 1.6% organic revenue decline to CHF 214.4 million in the first half of 2026 ...

medmix boosts margins and cash flow despite softer H1 revenue

Integral Diagnostics Ltd. ( ($AU:IDX) ) has shared an announcement. Integral Diagnostics Limited has scheduled the release of its fiscal year 2026 ...

Integral Diagnostics sets date for FY26 results release and investor call

The latest announcement is out from Bluejay Diagnostics ( ($BJDX) ). On July 21, 2026, Bluejay Diagnostics announced it had completed patient enrol...

Bluejay Diagnostics Completes Enrollment in SYMON-II Sepsis Study

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Vanda (VNDA) and Celldex (CLDX) with bullish sentime...

Analysts Are Bullish on Top Healthcare Stocks: Vanda (VNDA), Celldex (CLDX)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Regeneron (REGN), Celldex (CLDX) and Nurix Therapeut...

Analysts Offer Insights on Healthcare Companies: Regeneron (REGN), Celldex (CLDX) and Nurix Therapeutics (NRIX)

Wells Fargo analyst Derek Archila maintained a Buy rating on Celldex yesterday and set a price target of $48.00. The company’s shares closed yester...

Wells Fargo Keeps Their Buy Rating on Celldex (CLDX)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Helus Pharma (HELP) and Celldex (CLDX) with bullish ...

Analysts Offer Insights on Healthcare Companies: Helus Pharma (HELP) and Celldex (CLDX)

Bank of America Securities analyst Jason Zemansky maintained a Buy rating on Syndax Pharmaceuticals today and set a price target of $29.00. Accordi...

Bank of America Securities Sticks to Its Buy Rating for Syndax Pharmaceuticals (SNDX)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on CSL (CMXHF), Danaher (DHR) and TransMedics Group (TM...

Analysts Offer Insights on Healthcare Companies: CSL (OtherCMXHF), Danaher (DHR) and TransMedics Group (TMDX)

Bell Potter analyst Martyn Jacobs maintained a Buy rating on Lumos Diagnostics Holdings Ltd. today and set a price target of A$0.25. Jacobs covers ...

Lumos Diagnostics Holdings Ltd. (LDX) Gets a Buy from Bell Potter

ADX Energy ( ($AU:ADX) ) has shared an update. ADX Energy Ltd has notified the ASX of a proposed securities issue, outlining plans for a substantia...

ADX Energy Plans Major Share and Options Placement on ASX

An update from ADX Energy ( ($AU:ADX) ) is now available. ADX Energy has secured firm commitments to raise A$3.58 million through a discounted shar...

ADX Energy raises A$3.58m to accelerate European oil and gas growth

In a report released yesterday, Jason Weaver from JonesTrading reiterated a Buy rating on Dynex Capital, with a price target of $14.75. According t...

JonesTrading Keeps Their Buy Rating on Dynex Capital (DX)

An announcement from Hines Global Income Trust, Inc. Class D ( ($ZHGIDX) ) is now available. On July 21, 2026, Hines Global Income Trust acquired t...

Hines Global Income Trust Acquires Charlotte Mixed-Use Asset

CNBC’s Jim Cramer says the market around artificial intelligence has become too concentrated and unpredictable to keep throwing new money into tech...

‘You’re Going to Be Slaughtered,’ Warns Jim Cramer to Tech Investors Before Intel, Tesla, and Alphabet Earnings

Gold may be getting a stronger underlying price floor than many traders realize, according to a new Goldman Sachs ($GS) note that says central bank...

Goldman Says Gold Could Reach $4,900 as Central Banks Keep Buying

MA Financial Group analyst Murray Connellan maintained a Buy rating on Dexus Industria REIT yesterday and set a price target of A$3.30. Connellan c...

Dexus Industria REIT (DXI) Receives a Buy from MA Financial Group

COSCO SHIPPING Energy Transportation Co ( ($HK:1138) ) has provided an announcement. COSCO SHIPPING Energy Transportation Co., Ltd., a major Chines...

COSCO SHIPPING Energy Wins EGM Backing and Adds New Executive Director

COSCO SHIPPING Energy Transportation Co ( ($HK:1138) ) has provided an update. COSCO SHIPPING Energy Transportation Co., Ltd. has announced the lat...

COSCO SHIPPING Energy Transportation Updates Board and Committee Structure

Barclays analyst Etzer Darout assigned a Buy rating to Syndax Pharmaceuticals today and set a price target of $37.00. According to TipRanks, Darout...

Syndax Pharmaceuticals (SNDX) Receives a New Rating from a Top Analyst

Gold and silver are holding important support zones after a volatile week, with both metals rebounding as softer U.S. inflation data and a weaker d...

Gold and Silver Hold Key Support as Inflation and Dollar Pressure Ease

Markets were pulled in different directions last week by conflicting macro, geopolitical, broad market, industry-specific, and individual company f...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	DX	$12.95	+1.09%	5.14M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	DX	$12.95	+1.1%	5.14M
3
4
5
6

DX

DX

Get Dynex Capital, Inc. Data in Excel

Get Dynex Capital, Inc. Data in Excel